BioNTech SE - ADR vs Boston Beer Company Inc — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.78B), while Boston Beer Company Inc trades at $168.61 (market cap $1.80B). The key difference: BioNTech SE - ADR is far larger — about 12.7× Boston Beer Company Inc's market cap. Which is the better fit depends on your goals.
| BNTX | SAM | |
|---|---|---|
Market Cap | $22.78B | $1.80B |
Sector | Health | Consumer Staples |
52-Week High | $119.34 | $260.05 |
52-Week Low | $83.89 | $161.08 |
Enterprise Value | $6.45B | $1.67B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →